CardieX Limited (ASX:CDX)

Market Cap	17.05M
Revenue (ttm)	6.28M
Net Income (ttm)	-13.23M
Shares Out	550.08M
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	38,709
Average Volume	384,524
Open	0.0310
Previous Close	0.0300
Day's Range	0.0310 - 0.0310
52-Week Range	0.0270 - 0.1750
Beta	1.04
RSI	46.23
Earnings Date	Aug 29, 2025

About CardieX

CardieX Limited engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that captures central hemodynamics and arterial stiffness for noninvasive measurement of vascular biomarkers including central aortic pressures and arterial stiffness indices. The company also provides medical devices and vascular biomarkers for hypertension, cardiovascular disease, and other vascular health disorders; an...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1994
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CDX

Financial Performance

In 2025, CardieX's revenue was 6.28 million, a decrease of -50.97% compared to the previous year's 12.81 million. Losses were -13.23 million, 95.5% more than in 2024.